• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-019
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/25/2020
Event Type  malfunction  
Manufacturer Narrative
Further information regarding this event has been requested.If returned, investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2020, a 19mm amplatzer septal occluder(aso) was selected for implant.When deploying the aso in the left atrium, the aso became detached from the delivery cable.The physician attempted to remove the aso percutaneously by a snare catheter but failed.An emergency surgery was performed on the same date.It was thought that the aso had not been connected firmly enough to the delivery cable during preparation; the physician attributes the issue to his procedure and not due to the aso failure.There was a delay in the procedure.
 
Manufacturer Narrative
Correction information for h1.Additional information for b5, g4, g7, h2, h6, and h10.An event of premature detachment of the device was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
On (b)(6) 2020, a 19mm amplatzer septal occluder (aso) was selected for implant.The device was prepped per instructions in the ifu.When deploying the aso in the left atrium, the aso became detached from the delivery cable.The physician attempted to remove the aso percutaneously by a snare catheter but failed.An emergency surgery was performed on the same day to remove the device.The physician attributes the premature detachment to be due to not connecting the device securely to the delivery cable during preparation.There was a delay in the procedure.The patient is currently stable and recovered from the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10317624
MDR Text Key200246420
Report Number2135147-2020-00331
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010168
UDI-Public00811806010168
Combination Product (y/n)N
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Model Number9-ASD-019
Device Catalogue Number9-ASD-019
Device Lot Number7042105
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/26/2020
Initial Date FDA Received07/23/2020
Supplement Dates Manufacturer Received08/14/2020
Supplement Dates FDA Received08/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-